The trial is a randomized, double-blind, placebo-controlled study to evaluate whether prophylaxis with the industry sponsor’s therapeutic compound reduces the incidence of COVID-19 among residents of nursing home facilities. The name of the company is being kept confidential for now.
Brown Technology Innovations
Date
May 1, 2020
COVID-19 Clinical Trial Industry Contract
Brown Technology Innovations executed a contract with an industry sponsor for a clinical trial to be overseen by Dr. Stefan Gravenstein, Professor of Medicine and Director, Division of Geriatrics and Palliative Care.